Suchergebnisse - "Smart, Jennifer I"

PubPharm (25)

1

Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Hahn, M. | Triplett, C. | Anderson, M. | +7

2

Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020

enthalten in: Diagnostic microbiology and infectious disease | 2022

von Duncan, L. | Hamed, K. | Smart, J. | +3

3

Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections : Results of a Phase 3, Randomized, Double-blind Trial (TARGET)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Overcash, J. | Kim, C. | Keech, R. | +11

4

A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients

enthalten in: The Pediatric infectious disease journal | 2021

von Bosheva, M. | Gujabidze, R. | Károly, �. | +4

5

Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Flamm, R. | Duncan, L. | Hamed, K. | +3

6

Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017)

enthalten in: Diagnostic microbiology and infectious disease | 2019

von Pfaller, M. | Flamm, R. | Duncan, L. | +5

7

Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Pfaller, M. | Flamm, R. | Mendes, R. | +5

8

Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014-2015

enthalten in: Infection and drug resistance | 2018

von Santerre Henriksen, A. | Smart, J. | Hamed, K.

9

In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015) : Potency Analysis by U.S. Census Divisions

enthalten in: Microbial drug resistance (Larchmont, N.Y.) | 2017

von Pfaller, M. | Sader, H. | Flamm, R. | +3

10

Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)

enthalten in: Journal of global antimicrobial resistance | 2017

von Duncan, L. | Sader, H. | Smart, J. | +2